• Asian Pacific Journal of Cancer Prevention
• /
• 제15권23호
• /
• pp.10277-10280
• /
• 2015

Background and Aim: Breast cancer (BC) is a heterogeneous disease and cell proliferation markers may help to identify subtypes of clinical interest. We here analyzed the correlation between cell proliferation determined by Ki67 and HG in BC patients undergoing preoperative chemotherapy (PCT). Materials and Methods: We obtained clinical/pathological data from patients with invasive BC treated at our institution from 1999 until 2012. Expression of estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor type 2 (HER2) and Ki67 were determined by immuno-histochemistry (IHC). Clinicopathological subtypes were defined as: Luminal A, ER and/or PR positive, HER2 negative, HG 1 or 2; Luminal B, ER and/or PR positive, HER2 negative or positive and/or HG 3; triple negative (TN), ER, PR and HER2 negative independent of HG; HER2 positive, ER, PR negative and HER2 positive, independent of HG. By using Ki67, a value of 14% separated Luminal A and B tumors, independently of the histological grade. We analyzed correlations between Ki67 and HG, to define BC subtypes and their predictive value for response to PCT. Results: 1,560 BC patients were treated in the period, 147 receiving PCT (9.5%). Some 57 had sufficient clinicopathological information to be included in the study. Median age was 52 years (26-72), with 87.7% invasive ductal carcinomas (n=50). We performed IHC for Ki67 in 40 core biopsies and 50 surgical biopsies, 37 paired samples with Ki67 before and after chemotherapy being available. There was no significant correlation between Ki67 and HG (p=0.237), both categorizing patients into different subtypes. In most cases Ki67 decreased after PCT (65.8%). Only 3 patients had pathologic complete response (cPR). Conclusions: In our experience we did not find associations between Ki67 and HG. Determination of clinicopathological luminal subtypes differs by using Ki67 or HG.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권22호
• /
• pp.9599-9602
• /
• 2014

Background: Postoperative adjuvant radiotherapy (RT) in the management of early stage endometrial cancer (EC) is still controversial. Here we report our institutional experience with patients who received postoperative RT for stage I-II EC over a period of 35 years and assess potential predictors of local recurrence (LR), distant metastasis (DM), and overall survival (OS). Materials and Methods: A total of 188 patients undergoing postoperative RT for stage IA-II EC between 1977 and 2012 were evaluated. Some 96 received median 46 Gy whole pelvic radiotherapy (WPRT) (range: 40-60 Gy), 37 were given WPRT with vaginal cuff therapy (VCT), and 55 received only VCT either with brachytherapy (BT) or stereotactic body radiotherapy (SBRT). Chemotherapy was given to 5 patients with uterine papillary serous carcinoma (UPSC). Logistic regression analysis was used to assess the effect of clinicopathological factors on LR, DM, and OS. Results: Median follow-up time was 11 years (range: 1-35 years). At the time of analysis, 34 patients were not alive. Of the 15 patients with LR, 7 (46.7%) recurred in the vaginal stump, 5 (33.3%) in the pelvic region, and 3 (20%) in the paraaortic nodal region, while 12 had distant metastasis. UPSC histology (p=0.027), sole VCT (p=0.041), high histologic grade (p=0.034), and age ${\geq}71$ (p=0.04) were poor prognostic factors on univariate analysis. Conclusions: In our patients receiving radiotherapy for early-stage EC, grade III disease and age ${\geq}71$ were associated with shorter OS whereas UPSC histology was an independent predictor for both LR and DM.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권12호
• /
• pp.7143-7147
• /
• 2013

Background: The survival outcomes for women presenting with early breast cancer are influenced by treatment decisions. In Malaysia, survival outcome is generally poor due to late presentation. Of those who present early, many refuse treatment for complementary therapy. Objective: This study aimed to explore the decision making experiences of women with early breast cancer. Materials and Methods: A qualitative study using individual in-depth interviews was conducted to capture the decision making process of women with early breast cancer in Malaysia. We used purposive sampling to recruit women yet to undergo surgical treatment. A total of eight participants consented and were interviewed using a semi-structured interview guide. These women were recruited from a period of one week after they were informed of their diagnoses. A topic guide, based on the Ottawa decision support framework (ODSF), was used to facilitate the interviews, which were audio recorded, transcribed and analysed using a thematic approach. Results: We identified four phases in the decision-making process of women with early breast cancer: discovery (pre-diagnosis); confirmatory ('receiving bad news'); deliberation; and decision (making a decision). These phases ranged from when women first discovered abnormalities in their breasts to them making final surgical treatment decisions. Information was vital in guiding these women. Support from family members, friends, healthcare professionals as well as survivors also has an influencing role. However, the final say on treatment decision was from themselves. Conclusions: The treatment decision for women with early breast cancer in Malaysia is a result of information they gather on their decision making journey. This journey starts with diagnosis. The women's spouses, friends, family members and healthcare professionals play different roles as information providers and supporters at different stages of treatment decisions. However, the final treatment decision is influenced mainly by women's own experiences, knowledge and understanding.

• 대한정형외과스포츠의학회지
• /
• 제11권1호
• /
• pp.24-29
• /
• 2012

목적: 상완 이두근 장두의 고정술을 시행하는데 있어 관절경을 이용한 간섭 나사못(interference screw) 고정술후의 임상적 결과를 분석하고자 하였다. 대상 및 방법: 2008년 1월부터 2010년 1월까지 상완 이두근 장두의 건 고정술을 시행한 환자를 대상으로 하였으며, 최소 1년 이상 추시가 가능하였던 30예를 대상으로 하였다. 그중 회전근개 파열을 동반한 경우는 20예였다. 결과는 VAS, ASES, 상완 이두근 구의 압통, 고정실패 및 변형의 정도로 판단하였다. 결과: 최종 추시시 모든 환자에서 수술 전에 비해서 VAS, ASES 점수는 의미 있게 호전되었으나(p<0.05), 최종 추시시 17%(5예)에서 상완 이두근 구의 통증이 존재하였고, 10%(3예)에서 고정실패 및 BAD (biceps apex distance)의 증가로 인한 Popeye 변형이 존재하였다. 또한 회전근개 파열을 동반한 군과 그렇지 않는 군에서는 최종 추시시 회전근개 파열이 없는 군에서 좋은 결과를 얻을 수 있었다(p<0.05). 결론: 상완 이두근 근위부 병변에 의한 통증이 있는 환자에서 관절경적 상완 이두근 장두의 건고정술은 모두 최종 추시시 좋은 결과를 얻을 수 있으나, 17%에서 상완 이두근 구의 압통이 존재하여 추가적인 연구가 필요할 것으로 사료된다.

• 한국수산과학회지
• /
• 제47권5호
• /
• pp.582-587
• /
• 2014

We investigated the effects of feeding rate on the growth, blood components, and histology of sub-adult olive flounder Paralichthys olivaceus. Optimum feeding rate (initial fish mean weight : $384.2{\pm}5.91g$) was determined under the optimum water temperature. Two replicated groups of fish were fed a commercial diet at rates of 0%, 0.3%, 0.5%, and 0.7% body weight (BW) per day, and to satiation. The feeding trial was conducted using a flow-through system with ten 1.2-metric ton aquaria receiving filtered seawater at $20-24.5^{\circ}C$ for 3 weeks. After the feeding trial, the weight gain (WG) and specific growth rate (SGR) were significantly higher in fish fed at 0.7% BW/day and those fed to satiation (0.9% BW/day) than in fish fed at other feeding rates or in the unfed fish. These parameters were negative and significantly lower in the unfed fish than in those fed the experimental diet at all feeding rates. There were no significant differences in WG and SGR among fish fed at 0.3 and 0.5% BW/day and among those fed at 0.7% BW/day and to satiation. The histological changes in the hepatopancreas, kidney, and anterior intestine of fish fed at 0, 0.5, and 0.9 % BW/day did not differ much. Broken-line regression analysis of weight gain showed that the optimum feeding rate of olive flounder weighing 384 g was 0.74% BW per day at the optimum water temperatures.

• 대한방사선치료학회지
• /
• 제18권2호
• /
• pp.67-73
• /
• 2006

목 적: 암 환자의 증가와 함께 방사선 치료기술도 날로 발전하고 있으며 이로인해 치료를 위해 사용되는 영상 및 데이터의 양들도 대폭 증가하는 결과를 가져오게 되어 이들을 저장, 보관, 관리하는데 많은 어려움이 있었다. 이러한 문제점 해결을 위해 과에서 발생되는 모든 영상 및 data의 PACS (picture archiving and communication system)화를 목적으로 의료정보팀의 협조 하에 본 System을 개발, 적용하게 되었다. 대상 및 방법: 본과 방사선치료 관리 시스템(RO-radiation oncology)에서 PACS에 접근할 수 있는 code를 부여한 후 영상은 R&V (Record and Verify: Varis vision, Varian, USA) 시스템 및 planning system에서 export 한다. 이때 DICOM (digital image and communication system) head에 있는 많은 정보들 중에서 필요한 정보를 이용하여 프로그램화 하였다. 결 과: 방사선종양학과에서 발생되는 모든 영상 및 자료 즉, 모의치료, CT, L-gram 영상, structure (normal organ & target volume), DRR (Digital Reconstruction Radiography), 선량 분포도, DVH (dose volume histogram) 등을 PACS에 구현 하였으며 과내 어느 컴퓨터에서도 선명히 영상을 볼 수 있고 출력할 수 있도록 하였다. 결 론: 본 시스템의 개발로 film less화가 가능하게 되어 현상 처리에 관련한 암실 공간과 유지비용이 소멸되었고 film 저장공간 및 film을 찾는데 소요되는 인력과 시간을 포함한 유, 무형의 경제적 비용뿐만 아니라 영상 저장을 위한 별도의 저장장치의 구입도 불필요하게 되었다. 아울러 방사선 치료를 위해 복잡하게 행해졌던 일련의 과정들이 본 시스템을 통해서 현재는 전산 상에서 쉽게 처리할 수 있게 되어 업무에 많은 도움이 될 것으로 사료된다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권18호
• /
• pp.8107-8112
• /
• 2016

Background and Aims: Colorectal cancer is the second most frequent cancer in Malaysia. We aimed to assess the validity and reliability of the Malaysian Chinese version of European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire core (QLQ-C30) in patients with colorectal cancer. Materials and Methods: Translated versions of the QLQ-C30 were obtained from the EORTC. A cross sectional study design was used to obtain data from patients receiving treatment at two teaching hospitals in Kuala Lumpur, Malaysia. The Malaysian Chinese version of QLQ-C30 was self-administered in 96 patients while the Karnofsky Performance Scales (KPS) was generated by attending surgeons. Statistical analysis included reliability, convergent, discriminate validity, and known-groups comparisons. Statistical significance was based on p value ${\leq}0.05$. Results: The internal consistencies of the Malaysian Chinese version were acceptable [Cronbach's alpha (${\alpha}{\geq}0.70$)] in the global health status/overall quality of life (GHS/QOL), functioning scales except cognitive scale (${\alpha}{\leq}0.32$) in all levels of analysis, and social/family functioning scale (${\alpha}=0.63$) in patients without a stoma. All questionnaire items fulfilled the criteria for convergent and discriminant validity except question number 5, with correlation with role (r = 0.62) and social/family (r = 0.41) functioning higher than with physical functioning scales (r = 0.34). The test-retest coefficients in the GHS/QOL, functioning scales and in most of the symptoms scales were moderate to high (r = 0.58 to 1.00). Patients with a stoma reported statistically significant lower physical functioning (p=0.015), social/family functioning (p=0.013), and higher constipation (p=0.010) and financial difficulty (p=0.037) compared to patients without stoma. There was no significant difference between patients with high and low KPS scores. Conclusions: Malaysian Chinese version of the QLQ-C30 is a valid and reliable measure of HRQOL in patients with colorectal cancer.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권8호
• /
• pp.3809-3816
• /
• 2016

Background: Increasing knowledge and awareness of cancer screening significantly influence health promotion behavior which could markedly reduce incidence rates. In many countries, health care providers are the principal source of information concerning cancer screening. This study was carried out to assess the level of knowledge concerning cancer screening among medical students, house officers and residents and to explore their attitude towards cancer screening practices. Materials and Methods: This cross-sectional study was conducted in Kasr Al Ainy Medical School at Cairo University in Egypt, with 300 undergraduate medical students and 150 postgraduates (interns and residents) enrolled. A pre-tested self-administered questionnaire was used to collect data from the study participants regarding personal and education-related information, knowledge about cancer screening and its sources, and attitude towards cancer screening. Results: More than 64% of participants had knowledge scores of ${\leq}10$ points (out of 24). The total knowledge score (out of 6 points) for breast cancer screening increased from $1.9{\pm}1.0$ to $2.3{\pm}1.2$ and $2.4{\pm}1.1$ for $4^{th}$, $5^{th}$ and $6^{th}$ year respectively, interns showed the highest score of $2.6{\pm}1.1$, P= 0.001. Year of enrollment at medical school was a significant positive predictor of acquiring knowledge about cancer screening (post graduate vs. undergraduate students) (OR= 1.30, C.I =1.01-1.63), lack of or none receiving of orientation/training about cancer screening was the sole negative significant predictor for proper knowledge about cancer screening (OR=0.50, C.I=0.31-0.82). Over 92% of students agreed that they had insufficient knowledge about cancer screening, 88.2% appraised the need to have enough knowledge in order to direct/advice patients, relatives and friends, and 93.7% required that the faculty should emphasize the importance of cancer screening in the delivered curricula at medical school. Conclusions: A relatively low to moderate level of knowledge about cancer screening was detected among the selected medical students regardless of their year of enrollment at medical school or their graduation status, which may implicate a negative impact on early cancer detection especially in a low resource country like Egypt.

• Journal of Gastric Cancer
• /
• 제9권3호
• /
• pp.128-135
• /
• 2009

목적: 동시성 및 이시성 간전이 위암환자들을 대상으로 임상병리학적 특성 및 예후의 차이에 대하여 알아보고 치료 방법에 따른 예후에 대하여 알아보고자 하였다. 대상 및 방법: 1992년 6월부터 2006년 12월까지 한양대학교병원 외과예서 치료받은 위암 환자 중 간전이가 발견된 67명의 환자를 대상으로 임상병리학적 특징 및 치료 방법에 대하여 후향적 분석을 시행하였다. 결과: 두 군의 임상병리학적 특성에 대한 비교에서 림프관 침윤 여부(P=0.041)와 혈관 침윤 여부(P=0.036)가 동시성군에서 유의하게 많았다. 전체 간전이 위암환자의 1년 생존율과 중앙생존기간은 38.9%, 9.2개월이며 동시성 간전이군에서는 30.9%. 9.2개월이었고 이시성 간전이군에서는 44.5%, 9.7개월로 두 군 사이에 통계학적으로 유의한 차이는 없었다(P=0.436). 치료 방법을 수술 혹은 영상의학적 중재술 등의 국소적 치료와 전신적 항암화학치료를 병행한 경우, 전신적 항암화학치료만 받은 경우, 치료 받지 않은 경우 등 세 가지로 나누었을 때 동시성 간전이군과 이시성 간전이군 사이에 치료 방법의 차이는 없었으며 두 군 모두에서 국소적 치료를 전신적 치료와 병행하였을 경우 생존율이 높았다(P<0.001). 결론: 간전이 위암에 있어서 간전이 병소의 발생 시점에 따른 예후의 차이는 없을 것으로 생각한다. 또한 간전이 발견 시점과 관계 없이 적응 예가 되는 경우 수술적 치료나 영상의학적 중재술 등의 적극적인 치료가 환자의 예후 향상에 기여할 수 있겠다.

• 대한치과보철학회지
• /
• 제48권3호
• /
• pp.215-223
• /
• 2010

연구 목적: 이 연구는 임플란트 식립 시 미세나사가 변연골에 발생시키는 스트레인을 조사하여, 변연골의 골유착에 장애를 줄 수 있는 골의 과부하 영역 이 미세나사에 의해 확장되는 양태를 평가하였다. 연구 재료 및 방법: 3종의 임플란트 식립 모델을 삼차원적 유한 요소분석으로 실험하였다. 대조 모델은 미세나사가 없이 주나사만 있는 $4.1{\times}10$ mm 임플란트 (Submerged model, Dentis Co, Daegu, Korea), type I은 미세나사가 있는 straight body, type II는 미세나사가 있는 7% tapered body로 설정하였다. 임플란트가 치밀골을 통과하는 3,600 단계의 식립 과정이 모사되었다. 유한요소 해석에는PC용으로 출시된DEFORM$^{TM}$ 3D (ver 5, SFTC, Columbus, OH, USA)가 사용되었다 결과:임플란트 외벽으로부터 1 mm 이내의 변연골 스트레인 영역은 대조모델에서의 4000 ${\mu}$-strain 보다 높았다. Type I 임플란트의 경우 임플란트 외벽으로부터 1-1.5 mm 영역 이내의 인접골이 과부하 영역에 속하였고, type II 임플란트의 경우에는 2 mm 이상이었다. 결론: 미세나사의 유무와 몸체의 테이퍼 유무에 따라 변연골 스트레인은 직접적인 영향을 받았고 대조모델에 비해 경부 미세나사가 있는 type I 및 type II 임플란트의 식립 시 변연골의 과부하 영역이 월등히 컸다.